Skip to content

logo

SEARCH icon
  • Investing News
  • Biotech
  • Oil & Gas
  • Health
  • Mining
  • Cannabis
  • Energy
  • Tech
  • Health
  • MORE
    • Entertainment
    • Real Estate
    • Cannabis
    • Trading Tips
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Biotech
  • Oil & Gas
  • Health
  • Mining
  • Cannabis
  • Energy
  • Tech
  • Health
  • MORE
    • Entertainment
    • Real Estate
    • Cannabis
    • Trading Tips
    • Food & Beverage

logo

icon

      HomeNuminus-PR

      Numinus-PR

      Alaska Air: Earnings and Revenues in Q2 Exceeded Expectations and Increased Yoy
      Numinus-PR

      Alaska Air: Earnings and Revenues in Q2 Exceeded Expectations and Increased Yoy

      July 26, 2023
      Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
      Health

      Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product

      October 20, 2021
      Numinus to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
      Health

      Numinus to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

      October 6, 2021
      Numinus Completes Acquisition of Neurology Centre of Toronto
      Health

      Numinus Completes Acquisition of Neurology Centre of Toronto

      September 24, 2021
      Numinus to Participate in Upcoming Investor Conferences in September 2021
      Health

      Numinus to Participate in Upcoming Investor Conferences in September 2021

      September 3, 2021
      Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology
      Health

      Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology

      July 30, 2021
      Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD
      Health

      Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD

      July 12, 2021
      Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology
      Health

      Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology

      July 6, 2021
      Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange
      Health

      Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

      June 29, 2021
      Numinus Announces Update to Escrow Release Schedule
      Health

      Numinus Announces Update to Escrow Release Schedule

      June 29, 2021
      1 2 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Micro Cap Watch.

      I want e-mail alerts, updates, and offers and agree to the MicroCapWatch privacy policy.

      Market Jar Media Inc. © 2026